Hospital Frequency of Cutaneous Melanoma in the Laboratory of Dermatopathology of the Centro Médico Docente La Trinidad, in the period January 2018 and August 2023.

Abstract

Melanoma was first described by Hippocrates in the 15th century BC, when he referred to it as the “fatal black tumor”, but it was not until 1806 when René Laënnac at the Faculty of Medicine in Paris named it melanosis from the Greek melas-black, an aggressive tumor, difficult to treat and with high mortality; It is the most aggressive, malignant and treatment-resistant skin tumor, which spreads rapidly and has the capacity to produce metastasis. The following research is an observational, descriptive, retrospective, cross-sectional study, where the hospital frequency of melanoma was studied at the Dermatopathology laboratory of the Centro Médico Docente La Trinidad, in the period between 2018 and August 2023. The population was made up of 659 biopsies of which the hospital frequency of melanoma represented 2.42%, 16 biopsies the predominant sex was male, with the 68.75%, and the most affected anatomic location was trunk in 37.5% of the diagnoses.